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There are very few data concerning the role played by cell-
mediated cytotoxicity, particularly at the molecular level, in the
course of psoriasis. Both cytotoxic T lymphocytes (CTL) and
natural killer cells contain in their granules the cytolytic protein
perforin, a mediator in cell-mediated cytotoxicity reactions. The
aim of this study was to analyze perforin expression in various
sets and subsets of perforin-positive peripheral blood lympho-
cytes in 17 patients with chronic psoriasis vulgaris in the
exacerbation phase. The results were compared with those of an
age- and sex-matched healthy control group (n= 21). Perforin
(intracellular antigen) and cell surface antigens were detected
using the simultaneous double-staining method. We found a
signi®cant increase in perforin (P) expression in the patient
group for CTL (CD3+ P+ cells), which are located mostly in
the CD8+ population of T lymphocytes (CD8+ P+ ). Key
words: psoriasis; perforin; cytotoxic T lymphocytes; NK cells.
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INTRODUCTION
Psoriasis is an in¯ammatory papulosquamous skin disease
which is immunologically characterized by increased kera-
tinocyte proliferation, in®ltration of in¯ammatory cells,
especially T lymphocytes, and production of in¯ammatory
cytokines, mostly of Th1 phenotype (1).
Immunological changes characteristic of psoriasis occur at
the systemic and local levels, in the region of the psoriatic
lesion in the skin (2). It is generally considered that T
lymphocytes play an important role in the pathogenesis of
psoriasis. Skin lesions in psoriatic patients are strongly
in®ltrated with T lymphocytes and, depending on the stage
of disease, CD4+ or CD8+ cells predominate. Variations in
the levels of these cells are observed in the peripheral blood
(1, 3, 4).
There are very few data concerning the role of lymphocyte
(cell)-mediated cytotoxicity (CMC), particularly at the
molecular level. Both cytotoxic T lymphocytes (CTL) and
natural killer (NK) cells are mediators in CMC reactions.
These cells are endowed with a potent cytolytic armamentar-
ium located in the cytoplasmic granules, containing the
cytolytic molecule perforin (pore-forming protein) and
associated serine esterases (granzymes). In unstimulated
peripheral blood lymphocytes perforin is constitutively
expressed in NK and gamma/delta TCR+ cells (high level
of expression) and in the subpopulation of CD8+ cells
expressing CD11b antigen (moderate expression). However,
perforin can be induced in the CD8+ CD11b- subpopulation
and in some CD4+ T cells (5, 6). Perforin is a mediator in
CMC reactions and the main function of granzymes is to
mediate target DNA degradation upon gaining entry into the
target cell through the presence of perforin pores (7).
According to a search of the literature, the role of perforin-
mediated cytotoxicity in psoriasis has not yet been investi-
gated, either in the peripheral blood or in lesions.
The aim of this study was to analyze perforin expression in
various sets and subsets of perforin-positive peripheral blood
lymphocytes, which are known to have different functions.
MATERIALS AND METHODS
Patients
This study was approved by the Ethics Committee of the Medical
Faculty, University of Rijeka. For ¯ow cytometric analyses 2 groups
of patients were recruited: (i) 17 patients (8 males, 9 females; 23 ± 60
years) who were in the early exacerbation phase of chronic psoriasis;
and (ii) 21 healthy persons (laboratory personnel and volunteer blood
donors; 9 males, 12 females; 20 ± 57 years) who served as controls.
Lymphocyte preparation
Heparinized venous peripheral blood (10 ml) was layered onto Ficoll/
Hypaque density gradient and centrifuged for 20 min at 800 g. Cells
accumulating at the interface were washed twice in RPMI 1640 and
resuspended at a ®nal concentration of 16106 peripheral blood
lymphocytes per sample in ¯uorescent-activated cell sorting (FACS)
buffer. Cell viability was checked using trypan blue.
Monoclonal antibodies
A murine antihuman perforin monoclonal antibody (MoAb) dG9
(IgG2b) was puri®ed from Balb/c ascites (produced by E. R. P.). The
following MoAbs were obtained conjugated to phycoerythrin from
Becton Dickinson (Mountain View, CA): Leu-4 (anti-CD3), Leu-3a
(anti-CD4), Leu-2a (anti-CD8), Leu-11b (anti-CD16) and Leu-19
(anti-CD56).
Simultaneous detection of cell surface and intracellular antigens by
¯ow cytometry
Our procedure for the simultaneous detection of intracellular
(perforin) and cell surface membrane antigens has been described
elsewhere (8). Brie¯y, peripheral blood lymphocytes were cultured
overnight at 37³C in complete RPMI. Non-adherent cells were
aliquoted (10
6
per aliquot), washed in FACS buffer and then ®xed in
100 ml PBS containing 4% paraformaldehyde, pH 7.4, for 10 min at
room temperature. After 2 washes in FACS buffer, the cells were
permeabilized with saponin buffer (0.1% saponin) (Sigma, Poole, UK)
for 20 min at room temperature. Anti-perforin MoAb in saponin
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buffer (3 mg/100 ml) was added to the cell suspension at a ®nal
concentration of 8 ± 10 mg per sample and incubated for 30 min at
room temperature. A second antibody (¯uorescein-conjugated goat
anti-mouse IgG; Becton Dickinson) was added for a further 30 min at
room temperature. Cell surface antigens were then labeled by
incubating for 30 min at room temperature with phycoerythrin-
conjugated MoAbs after the integrity of the membranes was restored
by a 10-min incubation in FACS buffer. In some experiments, only
cell surface labeling was performed. An irrelevant isotype-matched
murine MoAb was used as a negative control.
Lymphocytes were gated on the basis of forward and side scatter. A
minimum of 104 cells were analyzed on a FACScan (Becton
Dickinson) and the results are shown as contour graphs. Thresholds
for positive staining were set at 52% using the negative control and
percentages of positive cells were obtained by subtracting the value of
the control.
Statistical analysis
Results were analyzed using Sigma Plot for Windows, version 1.02
(Jandel Scienti®c). Statistical analyses were performed using a
Student’s t-test 1-way analysis for comparison of means.
RESULTS
Lymphocyte subpopulations (T and NK cells) and total
perforin-positive cells
Signi®cant increases in CD3+ and CD8+ cells in the
peripheral blood lymphocytes of psoriatic patients in the
acute phase of disease were found compared to healthy
controls (Fig. 1). The incidence of CD3+ cells increased from
62% to 74.4% and the incidence of CD8+ cells increased
from 23.2% to 36.5% (p50.001). There was no difference
between the healthy control group and the patient group in
terms of either CD4+ T lymphocytes or both markers of NK
cells (CD16+ and CD56+ ). The percentage of lymphocytes
containing cytolytic molecule perforin (P+ cells) was slightly
higher in the patient group than in the healthy control group,
but this difference was not signi®cant (Fig. 1). The incidence
of total P+ lymphocytes was 31.4% for the patient group and
27% for the healthy controls.
Double positive peripheral blood lymphocytes
Double positive cells (simultaneously perforin-positive and
surface marker-positive) are represented as a fraction of the
total peripheral blood lymphocytes counted (10,000 cells),
which is set at 100% (Fig. 2). A signi®cant increase in perforin
expression was found in the patient group for the population
of T lymphocytes, i.e. CD3+ P+ cells (19.2% vs. 10%;
p50.02). This increase occurred mostly in the CD8+
population of T lymphocytes (CD8+ P+ ), which was
signi®cantly higher in the patient group (p50.01). A slight
but non-signi®cant increase was also found for CD4+ P+
cells. There was no signi®cant difference for both populations
of NK cells (CD16+ P+ and CD56+ P+ ), in spite of the fact
that slightly lower levels were found in the psoriasis group.
DISCUSSION
It has been shown that the perforin-mediated cytolytic
pathway plays a role in the rejection of foreign tissue,
autoimmunity, control of tumor growth and viral infections
and infections by intracellular pathogens (9 ± 11), and is
greatly weakened in elderly subjects (8). In the cytotoxic
pathway mediated by regulated secretion of granules the
formation of membrane pores by perforin is a prerequisite for
apoptosis of the target cell (12, 13). In addition to perforin the
main protein component of granules is a group of serine
proteases known as granzymes (14). Their main function is to
mediate target DNA degradation upon gaining entry to the
target cell by means of perforin pores (7).
In the present investigation we noticed signi®cant differ-
ences in some lymphocyte subpopulations between healthy
controls and psoriatic patients. The cloning of skin-in®ltrating
lymphocytes from lesional skin showed that some clones are
cytotoxic against autologous lymphoblastic cell lines. Cyto-
lytic clones were mostly CD4+ and some exhibited
characteristics of NK cells (15). Eruption of acute psoriatic
lesions coincides with the epidermal in¯ux and activation of
CD4+ T cells, whereas spontaneous disease resolution is
associated with recruitment of CD8+ cells (16). Accordingly,
the absence of CD8+ cytotoxic clones in the experiments
Fig. 1. The percentages of T and NK lymphocyte populations and
total perforin-positive cells (P+ ) in peripheral blood lymphocytes
of patients in the exacerbation phase of chronic psoriasis vulgaris
compared to healthy controls. *p50.001.
Fig. 2. The percentage of double positive lymphocytes [perforin-
positive (P+ ) and surface marker-positive] in peripheral blood of
patients in the exacerbation phase of chronic psoriasis vulgaris
compared to healthy controls. *p50.02, **p50.01.
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cited above could be the consequence of the clinical phase of
the disease, when samples were collected.
Cellular in®ltrates in lesional skin consist largely of HLA-
DR+ /IL-2R+ T cells, i.e. activated T cells (17), and perforin
expression in T cells is a marker for functionally activated
cytotoxic cells in situ (5, 7). Evidence of the role of granzyme
B-expressing CD8-positive T cells and perforin-positive cells
in the apoptosis of keratinocytes in lichen planus, which is
also thought to be a T cell-mediated disease, has been
obtained (18). However, perforin expression in psoriatic
patients was not analyzed either in situ or in cloned cells.
There was no signi®cant difference in perforin expression in
NK cell subpopulations between psoriatic patients and
healthy controls. The percentage of P+ cells was slightly
lower in the patient group. This might mean either that these
cells are shifted to the lesional skin or that NK cells and
lymphocyte-mediated antibody-dependent cytotoxicity do not
play an important role in the pathogenesis of psoriasis.
Although preliminary, the results of perforin expression in
the T lymphocytes of psoriatic patients are interesting. They
point to the role that perforin could play in the pathogenesis
of the disease, particularly in the exacerbation phase. We have
examined perforin expression in CTL, both CD4+ P+ and
CD8+ P+ cells, in order to directly address the question of
whether a speci®c cell population containing perforin in its
granules is operative in the disease process in vivo. The results
clearly showed that CD3+ P+ cells are upregulated com-
pared to healthy controls in the phase of disease exacerbation,
and that this increase is mostly located in the CD8+ P+
subpopulation (p50.01). CD8+ P+ cells are the subpopula-
tion of CD8+ T lymphocytes with cytotoxic potential and
rapid killing of target cells bearing MHC class I molecules
and appropriate antigen (5, 7). These cells could participate
directly in the switching off of the in¯ammatory process via
HLA class I-mediated recognition of the psoriasis epitope(s)
(16). Investigations of perforin expression in the T lympho-
cytes at various disease stages and simultaneous detection in
the peripheral blood and lesional skin, which are in progress
in our laboratory, could shed light on the potential role of
cytolytic pathways in the clinical course of the disease.
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